However, the presence of multiple disease phenotypes and the absence of JAK2 mutation in some cases of MPN indicates that additional genetic lesions or/and aberrant signaling pathways may be involved in the pathogenesis and progression of the MPN [1, 2]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.